Company Filing History:
Years Active: 2013
Title: Danli Wu: Innovator in Hepatology
Introduction
Danli Wu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of hepatology through her innovative research and patents. Her work focuses on liver health and regeneration, which is crucial for treating various liver-related ailments.
Latest Patents
Danli Wu holds a patent for "Hepatopoietin and use thereof." This patent describes a hepatopoietin PCn (HPPCn) and its homologous proteins, which have the ability to promote hepatocyte proliferation in vitro. Additionally, these proteins can enhance liver regeneration in vivo, inhibit the growth of tumor cells, and promote the apoptosis of tumor cells. The hepatopoietin PCn (HPPCn) and its homologous proteins are particularly useful for treating acute and chronic liver injury, as well as liver fibrosis. She has 1 patent to her name.
Career Highlights
Danli Wu is affiliated with the Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA. Her role at this esteemed institution allows her to engage in cutting-edge research that has the potential to impact liver disease treatment significantly.
Collaborations
Some of her notable coworkers include Zuze Wu and Bingxing Shi, who contribute to her research endeavors and collaborative projects.
Conclusion
Danli Wu's innovative work in hepatology exemplifies the importance of research in advancing medical treatments for liver conditions. Her contributions are paving the way for new therapeutic approaches that could benefit many patients suffering from liver diseases.